 |
Previous Article | Next Article 
The Journal of Neuroscience, December 15, 2002, 22(24):10627-10632
Mice Lacking M2 and M3 Muscarinic
Acetylcholine Receptors Are Devoid of Cholinergic Smooth Muscle
Contractions But Still Viable
Minoru
Matsui1, 2,
Daisuke
Motomura2,
Toru
Fujikawa3,
Jian
Jiang3,
Shin-ichi
Takahashi2,
Toshiya
Manabe1, and
Makoto M.
Taketo2, 4
1 Division of Neuronal Network, Department of Basic
Medical Sciences, The Institute of Medical Science, The University of
Tokyo, Tokyo 108-8639, Japan, 2 Laboratory of Biomedical
Genetics, Graduate School of Pharmaceutical Sciences, The University of
Tokyo, Tokyo 113-0033, Japan, and 3 Banyu Tsukuba Research
Institute (Merck), Ibaraki 300-2611, Japan, and
4 Department of Pharmacology, Graduate School of Medicine,
Kyoto University, Kyoto 606-8501, Japan
Cholinergic agents elicit prominent smooth muscle
contractions via stimulation of muscarinic receptors that comprise five distinct subtypes (M1-M5). Although
such contractions are important for autonomic organs, the role of each
subtype has not been characterized precisely because of the poor
selectivity of the currently available muscarinic ligands. Here, we
generated a mutant mouse line (M2 / M3 / mice) lacking M2 and M3 receptors that are
implicated in such cholinergic contractions. The relative contributions
of M2 and M3 receptors in vitro
was ~5 and 95% for the detrusor muscle contraction and ~25 and
75% for the ileal longitudinal muscle contraction, respectively. Thus,
M1, M4, or M5
receptors do not seem to play a role in such contractions. Despite the
complete lack of cholinergic contractions in vitro,
M2 / M3 / mice were viable, fertile, and free of apparent intestinal complications. The urinary bladder was
distended only in males, which excludes a major contribution by
cholinergic mechanisms to the urination in females. Thus, cholinergic mechanisms are dispensable in gastrointestinal motility and female urination. After 10 Hz electrical field stimulation,
noncholinergic inputs were found to be increased in the ileum of
M2 / M3 / females, which may account for
the lack of apparent functional deficits. Interestingly, the
M2 / M3 / mice had smaller ocular pupils
than M3-deficient mice. The results suggest a novel
role of M2 in the pupillary dilation, contrary to the well
known cholinergic constriction. These results collectively suggest that
an additional mechanism operates in the control of pupillary
constriction-dilatation.
Key words:
acetylcholine; muscarinic receptors; smooth muscle
contraction; gene targeting; intestinal motility; ocular pupils
Copyright © 2002 Society for Neuroscience 0270-6474/02/222410627-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
E. Tarusawa, K. Matsui, T. Budisantoso, E. Molnar, M. Watanabe, M. Matsui, Y. Fukazawa, and R. Shigemoto
Input-Specific Intrasynaptic Arrangements of Ionotropic Glutamate Receptors and Their Impact on Postsynaptic Responses
J. Neurosci.,
October 14, 2009;
29(41):
12896 - 12908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Tran, A. Chang, M. Matsui, and F. J. Ehlert
Estimation of Relative Microscopic Affinity Constants of Agonists for the Active State of the Receptor in Functional Studies on M2 and M3 Muscarinic Receptors
Mol. Pharmacol.,
February 1, 2009;
75(2):
381 - 396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Shah, S. Khurana, K. Cheng, and J.-P. Raufman
Muscarinic receptors and ligands in cancer
Am J Physiol Cell Physiol,
February 1, 2009;
296(2):
C221 - C232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shekhar, W. Z. Potter, J. Lightfoot, J. Lienemann, S. Dube, C. Mallinckrodt, F. P. Bymaster, D. L. McKinzie, and C. C. Felder
Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
Am J Psychiatry,
August 1, 2008;
165(8):
1033 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Ehlert, S. Ahn, K. J. Pak, G. J. Park, M. S. Sangnil, J. A. Tran, and M. Matsui
Neuronally Released Acetylcholine Acts on the M2 Muscarinic Receptor to Oppose the Relaxant Effect of Isoproterenol on Cholinergic Contractions in Mouse Urinary Bladder
J. Pharmacol. Exp. Ther.,
August 1, 2007;
322(2):
631 - 637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takeuchi, K. Tanaka, H. Nakajima, M. Matsui, and Y.-T. Azuma
M2 and M3 muscarinic receptors are involved in enteric nerve-mediated contraction of the mouse ileum: findings obtained with muscarinic-receptor knockout mouse
Am J Physiol Gastrointest Liver Physiol,
January 1, 2007;
292(1):
G154 - G164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-K. Ng, W. C. de Groat, and H.-Y. Wu
Muscarinic regulation of neonatal rat bladder spontaneous contractions
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2006;
291(4):
R1049 - R1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Tran, M. Matsui, and F. J. Ehlert
Differential Coupling of Muscarinic M1, M2, and M3 Receptors to Phosphoinositide Hydrolysis in Urinary Bladder and Longitudinal Muscle of the Ileum of the Mouse
J. Pharmacol. Exp. Ther.,
August 1, 2006;
318(2):
649 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Wegener, V. Schulla, A. Koller, N. Klugbauer, R. Feil, and F. Hofmann
Control of intestinal motility by the Cav1.2 L-type calcium channel in mice
FASEB J,
June 1, 2006;
20(8):
1260 - 1262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-M. Zhang, S.-R. Chen, M. Matsui, D. Gautam, J. Wess, and H.-L. Pan
Opposing Functions of Spinal M2, M3, and M4 Receptor Subtypes in Regulation of GABAergic Inputs to Dorsal Horn Neurons Revealed by Muscarinic Receptor Knockout Mice
Mol. Pharmacol.,
March 1, 2006;
69(3):
1048 - 1055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Belmonte
Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
November 1, 2005;
2(4):
297 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Padley, D. H. Overstreet, P. M. Pilowsky, and A. K. Goodchild
Impaired cardiac and sympathetic autonomic control in rats differing in acetylcholine receptor sensitivity
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H1985 - H1992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takeuchi, K. Fujinami, H. Goto, A. Fujita, M. M. Taketo, T. Manabe, M. Matsui, and F. Hata
Roles of M2 and M4 Muscarinic Receptors in Regulating Acetylcholine Release From Myenteric Neurons of Mouse Ileum
J Neurophysiol,
May 1, 2005;
93(5):
2841 - 2848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Ehlert, M. T. Griffin, D. M. Abe, T. H. Vo, M. M. Taketo, T. Manabe, and M. Matsui
The M2 Muscarinic Receptor Mediates Contraction through Indirect Mechanisms in Mouse Urinary Bladder
J. Pharmacol. Exp. Ther.,
April 1, 2005;
313(1):
368 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Ehlert, J. C.-H. Hsu, K. Leung, A. G. Lee, D. Shehnaz, and M. T. Griffin
Comparison of the Antimuscarinic Action of p-Fluorohexahydrosiladifenidol in Ileal and Tracheal Smooth Muscle
J. Pharmacol. Exp. Ther.,
February 1, 2005;
312(2):
592 - 600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-E. Andersson and A. J. Wein
Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence
Pharmacol. Rev.,
December 1, 2004;
56(4):
581 - 631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-E. Andersson and A. Arner
Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology
Physiol Rev,
July 1, 2004;
84(3):
935 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Callaghan, S.D. Koh, and K.D. Keef
Muscarinic M2 Receptor Stimulation of Cav1.2b Requires Phosphatidylinositol 3-Kinase, Protein Kinase C, and c-Src
Circ. Res.,
March 19, 2004;
94(5):
626 - 633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Griffin, M. Matsui, D. Shehnaz, K. Z. Ansari, M. M. Taketo, T. Manabe, and F. J. Ehlert
Muscarinic Agonist-Mediated Heterologous Desensitization in Isolated Ileum Requires Activation of Both Muscarinic M2 and M3 Receptors
J. Pharmacol. Exp. Ther.,
January 1, 2004;
308(1):
339 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Struckmann, S. Schwering, S. Wiegand, A. Gschnell, M. Yamada, W. Kummer, J. Wess, and R. V. Haberberger
Role of Muscarinic Receptor Subtypes in the Constriction of Peripheral Airways: Studies on Receptor-Deficient Mice
Mol. Pharmacol.,
December 1, 2003;
64(6):
1444 - 1451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Matsui, M. T. Griffin, D. Shehnaz, M. M. Taketo, and F. J. Ehlert
Increased Relaxant Action of Forskolin and Isoproterenol against Muscarinic Agonist-Induced Contractions in Smooth Muscle from M2 Receptor Knockout Mice
J. Pharmacol. Exp. Ther.,
April 1, 2003;
305(1):
106 - 113.
[Abstract]
[Full Text]
|
 |
|
|

|